Julia Madsen - 02 Jun 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Sr. VP and GM, Life Sciences
Issuer ticker: STE
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:33:34 UTC
Prior SEC filing: 03 Jun 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Julia Madsen filed Form 4 for STERIS plc (STE) on 04 Jun 2026.

Key facts

This page summarizes Julia Madsen's Form 4 filing for STERIS plc (STE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:33.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001819129 Primary reporting owner

Madsen Julia

Relationship: Sr. VP and GM, Life Sciences
Address: 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Award

Transaction value
Shares: +2,316
Change %: +22%
Price: $0.000000^*
Shares after: 12,818
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

STE transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -127
Change %: -0.99%
Price: $209.76^*
Shares after: 12,691
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +8,080
Change %
Price: $0.000000^*
Shares after: 8,080
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 8,080
Exercise price: $230.74
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

As of June 2, 2026, 5,398 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 666 on June 3, 2026; 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

Footnote F2

127 shares were withheld from the 352 restricted shares that vested on June 2, 2026. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

Footnote F3

This option becomes exercisable as follows: 2,020 on June 2, 2027, 2,020 on June 2, 2028, 2,020 on June 4, 2029 and 2,020 on June 3, 2030.